This week we look at the ethical challenges facing neuroscientists as they recruit patients for clinical research. We also look at a ride share company entering the health care space and what it may mean for clinical trial recruitment, CBD as a prevention measure for COVID-19, deltacron and ... READ MORE >
vaccine
5 things to know in life sciences: Week of September 6
As the threat of the delta variant continues to mount, the Biden administration has released plans to extend its vaccine mandate to U.S. companies. Affecting over 80 million U.S. workers, we expect there to be significant conversation on this topic in the coming months. This week, we also dig into ... READ MORE >
5 things to know in life sciences: Week of June 14
Given the high volume of mergers and acquisitions in life sciences, changes in the leadership and focus of the Federal Trade Commission will be closely watched in the coming months as scrutiny could shift to the technology industry. We examine the possible impact below. We also look at CureVac’s ... READ MORE >
5 things to know in life sciences: Week of March 22
In this week’s life sciences roundup: the AstraZeneca-Oxford COVID-19 vaccine has faced challenging headwinds in the past week as several European Union countries paused distribution pending additional information from the European Medicines Agency, and as the National Institute of Allergy and Infectious ... READ MORE >
CHART OF THE DAY: How COVID-19 vaccines compare on cold storage requirements
About 100 million people tuned in to the watch the Super Bowl on Sunday – that’s almost four times the number of Americans who have received their first jab of a COVID-19 vaccine. While the world’s largest vaccination effort is not going 100% according to plan, the Centers for Disease Control and ... READ MORE >
5 things to know in life sciences: Week of Feb. 1
In this week’s roundup, we examine why more drug manufacturers are not stepping in to help produce mRNA-based COVID-19 vaccines. While some may think drug manufacturing facilities should be able to easily pivot to produce these vaccines, the reality is much more complicated. We also look at investment ... READ MORE >
5 things to know in life sciences: Week of Jan. 18
Now that President Joe Biden has taken office, there will soon be a host of new faces in positions with significant influence over the life sciences industry, as the first item in our roundup this week explains. These include new leaders at the Centers for Disease Control and Prevention and the Department ... READ MORE >
5 things to know this week in life sciences: Week of Jan. 4
Each year, pharma companies make updates to their price lists in January. This reliably generates headlines and, occasionally, congressional hearings. In this week’s industry roundup, we take a look at the recent price increases and how they compare to last year’s. We also look at the ongoing battle over ... READ MORE >
5 things to know this week in life sciences: Week of Dec. 21
With approval of Moderna’s COVID-19 vaccine last week for emergency use, many of us are looking forward to getting vaccinated with the hope that it will help us return to a more normal life. While looking forward, this is also a good time to reflect on the decades of work that laid the groundwork for this ... READ MORE >
CHART OF THE DAY: Vaccine doses for the global population
With the U.S. Food and Drug Administration set to review Pfizer and BioNTech’s COVID-19 vaccine this week for emergency use authorization and Moderna’s vaccine next week, we have passed the “if” phase of questions around the vaccine. Now, the focus turns to the “when and how” of distribution. The ... READ MORE >